Technology-Enhanced Asthma Care in Children at Clinic and Home Study

Inclusion criteria

• Caregivers must be at least 18 years old (defined as parent or legal guardian)
• The child (patient) has a diagnosis of asthma associated with a clinic visit in the electronic health record
• The child is between the ages of 4-17 years old at the time of recruitment
• The study is interested in the self-management of asthma by caregivers, whom are still primarily responsible for their child's chronic disease management.
• Children younger than 4 years old will not be included in this study as the diagnosis of asthma is typically difficult to confirm in younger ages.
• The child is prescribed inhaled corticosteroid or corticosteroid/long-acting beta agonist combination for daily use. The patient can have an inhaled corticosteroid/long-acting beta agonist for both daily preventive and rescue use, as in Single Maintenance and Reliever Therapy (SMART).
• Persistent or un controlled asthma based on NHLBI guidelines40; Any 1 of the following:
• In past month, \>2 days per week with asthma symptoms
• \>2 days per week with rescue medication use
• \>2 days per month with nighttime awakenings (for children who are not taking a controller asthma medication) OR \>2 days per month with nighttime awakenings (for children who are currently taking a controller asthma medication)
• \>2 asthma episodes during the past year that required systemic corticosteroids
• The child is a patient in Primary Care Uptown, Primary Care Deming, Allergy, or Pulmonary Clinics at LCH
• PARENT-CHILD PAIR

Exclusion criteria

• The caregiver has a smartphone that is not compatible with the Hailie® app.
• The patient is prescribed a controller (preventive) or rescue inhaler medication to which the Hailie electronic sensor cannot affix.
• The caregiver is unable to speak and understand English.
• a. With this trial, the intent is to first establish feasibility and broaden to different languages in future.
• The child has clinically significant, comorbid diagnoses, such as cystic fibrosis, cyanotic heart disease, or bronchopulmonary dysplasia, that could interact with their assessment of asthma-related measures.
• The family has active Department of Child and Family Services (DCFS) involvement
• The participant is enrolled in another asthma intervention study at the time of enrollment to this study.
• Child or sibling living in the same home was previously enrolled in this study.
• Consent is not obtained from the parent/guardian.
• Parent/guardian does not pass the test of understanding at study enrollment.
• HEALTH CARE PROVIDER INCLUSION CRITERIA (IMPLEMENTATION OUTCOMES)
• Participant is an employee of LCH system
• Works at or supports the operations of Primary Care Uptown, Primary Care Deming, Allergy, or Pulmonary Clinics at LCH
• Able to provide informed consent
• HEALTH CARE PROVIDER EXCLUSION CRITERIA (IMPLEMENTATION OUTCOMES)
• \. Participant departs LCH and is no longer an active employee at the time of assessment